Malaria vaccines
Malaria Vaccines
Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. It is preventable and curable. Malaria vaccines are a critical tool in the fight against this disease.
History[edit | edit source]
The development of malaria vaccines has been a challenging process that has spanned over several decades. The first malaria vaccine, RTS,S/AS01 (trade name Mosquirix), was approved by European regulators in 2015. This vaccine was developed by GlaxoSmithKline in partnership with the PATH Malaria Vaccine Initiative.
Types of Malaria Vaccines[edit | edit source]
There are three main types of malaria vaccines that are currently under development: pre-erythrocytic vaccines, blood-stage vaccines, and transmission-blocking vaccines.
Pre-erythrocytic Vaccines[edit | edit source]
Pre-erythrocytic vaccines target the parasite during the initial stage of its life cycle, when it first enters the human host from the mosquito. The RTS,S/AS01 vaccine is an example of a pre-erythrocytic vaccine.
Blood-stage Vaccines[edit | edit source]
Blood-stage vaccines aim to control the symptoms of malaria by targeting the parasites once they have infected the red blood cells. These vaccines are designed to reduce the severity of the disease.
Transmission-blocking Vaccines[edit | edit source]
Transmission-blocking vaccines are designed to prevent the spread of malaria by blocking the development of the parasite in the mosquito. These vaccines aim to reduce the transmission of the disease.
Effectiveness[edit | edit source]
The effectiveness of malaria vaccines varies. The RTS,S/AS01 vaccine has been shown to provide partial protection against malaria in young children. However, no vaccine provides complete protection against the disease.
Future Developments[edit | edit source]
Research is ongoing to develop more effective malaria vaccines. This includes the use of new technologies, such as genetic engineering, to create vaccines that can provide better protection against the disease.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
